BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24393522)

  • 1. Completeness and timeliness: Cancer registries could/should improve their performance.
    Zanetti R; Schmidtmann I; Sacchetto L; Binder-Foucard F; Bordoni A; Coza D; Ferretti S; Galceran J; Gavin A; Larranaga N; Robinson D; Tryggvadottir L; Van Eycken E; Zadnik V; Coebergh JW; Rosso S
    Eur J Cancer; 2015 Jun; 51(9):1091-8. PubMed ID: 24393522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
    Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method.
    Hackl M; Waldhoer T
    Eur J Public Health; 2013 Oct; 23(5):889-93. PubMed ID: 23002230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
    Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do cancer registries in europe estimate completeness of registration?
    Schmidtmann I; Blettner M
    Methods Inf Med; 2009; 48(3):267-71. PubMed ID: 19387506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index].
    Ajiki W; Tsukuma H; Oshima A
    Nihon Koshu Eisei Zasshi; 1998 Oct; 45(10):1011-7. PubMed ID: 9893469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data quality at population-based cancer registries in Colombia.
    Cendales R; Pardo C; Uribe C; López G; Yepez MC; Bravo LE
    Biomedica; 2012; 32(4):536-44. PubMed ID: 23715229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completeness of a newly implemented general cancer registry in northern France: Application of a three-source capture-recapture method.
    Plouvier SD; Bernillon P; Ligier K; Theis D; Miquel PH; Pasquier D; Rivest LP
    Rev Epidemiol Sante Publique; 2019 Jul; 67(4):239-245. PubMed ID: 31146902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completeness of ascertainment by cancer registries: putting bounds on the number of missing cases.
    Silcocks PB; Robinson D
    J Public Health (Oxf); 2004 Jun; 26(2):161-7. PubMed ID: 15284320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The completeness and timeliness of cancer registration and the implications for measuring cancer burden.
    Donnelly C; Cairnduff V; Chen JJ; Kearney T; Fitzpatrick D; Fox C; Gavin A
    Cancer Epidemiol; 2017 Aug; 49():101-107. PubMed ID: 28600946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Difficult Decisions in Public Health Surveillance: Striking the Right Balance between Timeliness and Completeness.
    Salemi JL; Tanner JP; Anjohrin SB; Rutkowski RE; Correia JA; Watkins SM; Kirby RS
    J Registry Manag; 2015; 42(2):48-61. PubMed ID: 26360106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance Evaluation of the National Cancer Registry in Sabah, Malaysia.
    Jeffree SM; Mihat O; Lukman KA; Ibrahim MY; Kamaludin F; Hassan MR; Kaur N; Myint T
    Asian Pac J Cancer Prev; 2016; 17(7):3123-9. PubMed ID: 27509940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of data quality at the Gambia national cancer registry.
    Shimakawa Y; Bah E; Wild CP; Hall AJ
    Int J Cancer; 2013 Feb; 132(3):658-65. PubMed ID: 22618962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Completeness of regional cancer registry data in Northwest Russia 2008-2017.
    Barchuk A; Tursun-Zade R; Nazarova E; Komarov Y; Tyurina E; Tumanova Y; Belyaev A; Znaor A
    BMC Cancer; 2023 Oct; 23(1):994. PubMed ID: 37853404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating completeness in cancer registries--comparing capture-recapture methods in a simulation study.
    Schmidtmann I
    Biom J; 2008 Dec; 50(6):1077-92. PubMed ID: 19067337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
    Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
    Parkin DM; Bray F
    Eur J Cancer; 2009 Mar; 45(5):756-64. PubMed ID: 19128954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
    Bray F; Parkin DM
    Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.